RhumbLine Advisers’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.56M | Buy |
173,028
+10,963
| +7% | +$606K | 0.01% | 1072 |
|
|
2025
Q1 | $7.84M | Buy |
162,065
+101
| +0.1% | +$4.88K | 0.01% | 1128 |
|
|
2024
Q4 | $6.25M | Sell |
161,964
-2,214
| -1% | -$85.5K | 0.01% | 1315 |
|
|
2024
Q3 | $7.39M | Buy |
164,178
+79,203
| +93% | +$3.56M | 0.01% | 1212 |
|
|
2024
Q2 | $2.94M | Sell |
84,975
-14
| -0% | -$485 | ﹤0.01% | 1681 |
|
|
2024
Q1 | $2.46M | Buy |
84,989
+1,697
| +2% | +$49.1K | ﹤0.01% | 1801 |
|
|
2023
Q4 | $1.91M | Buy |
83,292
+483
| +0.6% | +$11.1K | ﹤0.01% | 1929 |
|
|
2023
Q3 | $1.38M | Buy |
82,809
+4,898
| +6% | +$81.7K | ﹤0.01% | 2035 |
|
|
2023
Q2 | $2.15M | Buy |
77,911
+3,202
| +4% | +$88.4K | ﹤0.01% | 1862 |
|
|
2023
Q1 | $1.72M | Buy |
74,709
+3,556
| +5% | +$81.8K | ﹤0.01% | 1883 |
|
|
2022
Q4 | $776K | Buy |
71,153
+636
| +0.9% | +$6.94K | ﹤0.01% | 2263 |
|
|
2022
Q3 | $594K | Buy |
70,517
+3,951
| +6% | +$33.3K | ﹤0.01% | 2415 |
|
|
2022
Q2 | $527K | Buy |
66,566
+20,140
| +43% | +$159K | ﹤0.01% | 2476 |
|
|
2022
Q1 | $1.1M | Buy |
46,426
+2,457
| +6% | +$58.2K | ﹤0.01% | 2098 |
|
|
2021
Q4 | $1.5M | Buy |
43,969
+1,274
| +3% | +$43.6K | ﹤0.01% | 2030 |
|
|
2021
Q3 | $757K | Buy |
42,695
+1,883
| +5% | +$33.4K | ﹤0.01% | 2355 |
|
|
2021
Q2 | $1.83M | Buy |
40,812
+7,597
| +23% | +$341K | ﹤0.01% | 1996 |
|
|
2021
Q1 | $860K | Sell |
33,215
-520
| -2% | -$13.5K | ﹤0.01% | 2251 |
|
|
2020
Q4 | $680K | Buy |
33,735
+4,289
| +15% | +$86.5K | ﹤0.01% | 2312 |
|
|
2020
Q3 | $576K | Sell |
29,446
-230
| -0.8% | -$4.5K | ﹤0.01% | 2222 |
|
|
2020
Q2 | $524K | Buy |
29,676
+13,005
| +78% | +$230K | ﹤0.01% | 2322 |
|
|
2020
Q1 | $118K | Buy |
16,671
+380
| +2% | +$2.69K | ﹤0.01% | 2739 |
|
|
2019
Q4 | $115K | Buy |
16,291
+751
| +5% | +$5.3K | ﹤0.01% | 2861 |
|
|
2019
Q3 | $187K | Buy |
15,540
+2,662
| +21% | +$32K | ﹤0.01% | 2767 |
|
|
2019
Q2 | $156K | Buy |
+12,878
| New | +$156K | ﹤0.01% | 2849 |
|
|
2018
Q2 | – | Sell |
-10,294
| Closed | -$88K | – | 2926 |
|
|
2018
Q1 | $88K | Buy |
+10,294
| New | +$88K | ﹤0.01% | 2762 |
|
|
2017
Q4 | – | Sell |
-10,096
| Closed | -$178K | – | 2853 |
|
|
2017
Q3 | $178K | Buy |
10,096
+20
| +0.2% | +$353 | ﹤0.01% | 2779 |
|
|
2017
Q2 | $114K | Buy |
+10,076
| New | +$114K | ﹤0.01% | 2883 |
|